Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

Share Price is delayed by 15 minutes
Get Live Data
751.00    12.50 (1.69%)
Bid:
748.00
Ask:
751.00
Spread: 3.00 (0.401%)
Market Cap: £855.69m
FEVR Live PriceLast checked at - London Stock Exchange

Intraday Fevertree Share Chart

Share Premium Cancellation Confirmation

13 Nov 2025 15:32

RNS Number : 4849H
Fevertree Drinks PLC
13 November 2025
 

13 November 2025

 

Fevertree Drinks plc

 ("Fever-Tree" or the "Company")

 

Share Premium Cancellation Confirmation

Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that, following the sanction by the High Court of England and Wales (the Court) of the reduction of capital by way of cancellation of the Company's share premium account (the Share Premium Cancellation) on 11 November 2025, the order of the Court confirming the Share Premium Cancellation and a statement of capital approved by the Court, were registered by the Registrar of Companies on 13 November 2025. Accordingly, the Share Premium Cancellation has now become effective.

 

Details of the Share Premium Cancellation were set out in the Notice of General Meeting and explanatory circular (the Circular) dated 11 September 2025, and the Share Premium Cancellation was approved by the shareholders of the Company at a general meeting of the Company on 17 October 2025.

 

The Share Premium Cancellation does not affect the rights attached to the Ordinary Shares and there is no change in the number of Ordinary Shares in issue (or their nominal value).

 

Ends

 

For further information:

 

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

 

Nominated Advisor and Broker - Investec Bank plc

David Flin I James Hopton | +44 (0)20 7597 5970

 

Corporate Broker - Jefferies International Limited

Ed Matthews I +44 (0)20 7029 8000

 

Financial PR advisers - FGS Global

Faeth Birch +44 (0)7768 943 171 I Anjali Unnikrishnan +44 (0)7826 534 233

Notes to Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 90 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEASFDFDESFFA
Date   Source Headline
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20269:35 amRNSTotal Voting Rights
27th May 20267:00 amRNSTransaction in Own Shares
22nd May 20269:51 amRNSHolding(s) in Company
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 20264:00 pmRNSGrant of Options
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20265:35 pmRNSDividend Timetable Update
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20265:11 pmRNS2025 Annual Report and Notice of AGM
14th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202611:02 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSFY25 Preliminary Results to 31 December 2025
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20262:47 pmRNSTotal Voting Rights
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.